BRAIN TUMOR, PRIMARY
Clinical trials for BRAIN TUMOR, PRIMARY explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, PRIMARY trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer trial adds chemo pill to standard care
Disease control Recruiting nowThis study tests whether adding the chemotherapy drug capecitabine to the standard temozolomide regimen can help people with newly diagnosed glioblastoma live longer without their tumor growing. About 67 adults who have completed initial radiation and chemo will take both pills a…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE1, PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New Tile-Shaped radiation device tested for brain tumors
Disease control Recruiting nowThis study is tracking 600 people with brain tumors who receive GammaTile therapy during surgery. GammaTile is a device that delivers radiation directly to the tumor site to help prevent regrowth. Researchers are measuring how long tumors stay under control and how patients feel …
Matched conditions: BRAIN TUMOR, PRIMARY
Sponsor: GT Medical Technologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Sound wave helmet aims to boost brain cancer treatment
Disease control Recruiting nowThis early study tests a special helmet that uses focused ultrasound to temporarily open the blood-brain barrier in people with glioblastoma. The goal is to let more chemotherapy reach the tumor. Ten adults who have already had surgery and standard chemo will receive the ultrasou…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE1 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
Blood samples from brain tumor patients could unlock future discoveries
Knowledge-focused Recruiting nowThis study is creating a collection of blood samples from 300 adults with primary or metastatic brain tumors. Researchers will analyze immune cells in the blood to better understand these tumors. The goal is to provide a resource for future studies, not to test a new treatment.
Matched conditions: BRAIN TUMOR, PRIMARY
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC